The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 diabetes mellitus

Journal of Human Genetics
Junichi KamimuraNaomichi Matsumoto

Abstract

Type 2 diabetes mellitus (T2DM) is a group of multifactorial disorders due to either defective insulin secretion or action. Despite the fact that numerous genetic researches of T2DM have been pursued, the pathogenic mechanisms remain obscure. We encountered a T2DM family associated with a balanced reciprocal translocation, t(3;9)(p21.31;q33.1). To isolate a candidate gene susceptible to T2DM, we constructed physical maps covering both the 3p and 9q breakpoints of the translocation in the family. Consequently, the inositol hexaphosphate kinase 1 gene ( IHPK1) (OMIM *606991) was found to be disrupted at the 3p21.31 breakpoint. We then carried out sequence analysis for all coding regions of IHPK1 in 405 unrelated T2DM patients in order to validate whether aberrations of the gene are common in T2DM patients, but we failed to detect any pathogenic changes. The disruption of IHPK1 or another predisposing gene affected by position effect of the translocation may explain the T2DM phenotype at least in this family. Alternatively, the IHPK1 disruption in the family is a chance association.

References

Sep 1, 1994·The Journal of Clinical Investigation·M LaaksoS S Deeb
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·S M VoglmaierS H Snyder
Sep 15, 1998·Human Molecular Genetics·D J Kleinjan, V van Heyningen
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Barbara L Triggs-RaineRobert A Hegele
Dec 28, 2002·Diabetes·Naoko IwasakiYasuhiko Iwamoto
Jun 6, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·K R OwenA T Hattersley

❮ Previous
Next ❯

Citations

Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rashna BhandariSolomon H Snyder
Aug 14, 2012·Advances in Biological Regulation·Christopher J Barker, Per-Olof Berggren
Nov 3, 2010·Advances in Enzyme Regulation·Cristina AzevedoAdolfo Saiardi
Jun 19, 2009·Advances in Enzyme Regulation·Christopher J BarkerPer-Olof Berggren
Mar 28, 2009·Journal of Cellular Physiology·Adam BurtonAdolfo Saiardi
Oct 25, 2013·The FEBS Journal·Mark P Thomas, Barry V L Potter
Nov 17, 2009·Advances in Enzyme Regulation·Bhaskarjyoti Sarmah, Susan R Wente
Nov 24, 2007·Science·Shinya Nagamatsu, Mica Ohara-Imaizumi
Jul 28, 2016·Chemical Society Reviews·Nathaniel W BrownDorothea Fiedler
Feb 23, 2013·Pharmacological Reviews·Christopher J Barker, Per-Olof Berggren
Jun 4, 2014·Angewandte Chemie·Mingxuan WuDorothea Fiedler
Jun 1, 2014·Molecular Endocrinology·Sookhee BangSangwon F Kim
Mar 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sandip MukherjeeAnutosh Chakraborty
Dec 29, 2017·Biological Reviews of the Cambridge Philosophical Society·Anutosh Chakraborty
Dec 20, 2013·Journal of the American Chemical Society·Alan M MarmelsteinDorothea Fiedler
Jun 11, 2015·ACS Chemical Biology·Florence J Williams, Dorothea Fiedler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.